FI862226A - Foerfarande foer framstaellning av kompositioner innehaollande vaevnadsplasminogen-aktivator. - Google Patents

Foerfarande foer framstaellning av kompositioner innehaollande vaevnadsplasminogen-aktivator. Download PDF

Info

Publication number
FI862226A
FI862226A FI862226A FI862226A FI862226A FI 862226 A FI862226 A FI 862226A FI 862226 A FI862226 A FI 862226A FI 862226 A FI862226 A FI 862226A FI 862226 A FI862226 A FI 862226A
Authority
FI
Finland
Prior art keywords
vaevnadsplasminogen
aktivator
foerfarande foer
foer framstaellning
kompositioner
Prior art date
Application number
FI862226A
Other languages
English (en)
Other versions
FI862226A0 (fi
FI85334B (fi
FI85334C (fi
Inventor
Michael Denis Johnston
Henry Berger
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521704A external-priority patent/GB8521704D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI862226A0 publication Critical patent/FI862226A0/fi
Publication of FI862226A publication Critical patent/FI862226A/fi
Publication of FI85334B publication Critical patent/FI85334B/fi
Application granted granted Critical
Publication of FI85334C publication Critical patent/FI85334C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
FI862226A 1985-05-28 1986-05-27 Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning. FI85334C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8513358 1985-05-28
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB8521704 1985-08-31
GB858521704A GB8521704D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (4)

Publication Number Publication Date
FI862226A0 FI862226A0 (fi) 1986-05-27
FI862226A true FI862226A (fi) 1986-11-29
FI85334B FI85334B (fi) 1991-12-31
FI85334C FI85334C (fi) 1992-04-10

Family

ID=26289289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862226A FI85334C (fi) 1985-05-28 1986-05-27 Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning.

Country Status (22)

Country Link
US (1) US5112609A (fi)
AT (1) AT391812B (fi)
AU (1) AU569429B2 (fi)
BE (1) BE904831A (fi)
CA (1) CA1297008C (fi)
CH (1) CH664495A5 (fi)
DE (1) DE3617753A1 (fi)
DK (1) DK163174C (fi)
ES (1) ES8706443A1 (fi)
FI (1) FI85334C (fi)
FR (1) FR2593393B1 (fi)
GB (1) GB2176703B (fi)
GR (1) GR861365B (fi)
HU (1) HU200695B (fi)
IL (1) IL78937A (fi)
IT (1) IT1191925B (fi)
LU (1) LU86445A1 (fi)
NL (1) NL8601354A (fi)
NO (1) NO171344C (fi)
NZ (1) NZ216306A (fi)
PT (1) PT82647B (fi)
SE (1) SE462893B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
AU593794B2 (en) * 1985-03-06 1990-02-22 Survival Technology Inc. Protein absorption enhancing agent
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
IE59895B1 (en) * 1986-05-12 1994-04-20 Wellcome Found Medicaments containing tissue plasminogen activator
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1990001334A1 (en) * 1988-08-05 1990-02-22 Codon Formulations for plasminogen activator using aspartate
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB9000629D0 (en) * 1990-01-11 1990-03-14 Porton Prod Ltd Tissue plasminogen activator
DE69312493T2 (de) * 1992-06-03 1998-01-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
CA2459120A1 (en) * 2001-09-07 2003-03-20 Kenneth S. S. Chang Human tissue urokinase type plasminogen activator formulation
US8617863B2 (en) * 2008-06-04 2013-12-31 Grifols Therapeutics Inc. Composition, method, and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (fi) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
ES8106836A2 (es) * 1979-07-27 1981-10-01 Fabre Sa Pierre Procedimiento de obtencion de un activador del plasminogeno
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
GR79202B (fi) * 1982-05-05 1984-10-22 Genentech Inc
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
WO1984001714A1 (en) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE59009964D1 (de) * 1989-09-13 1996-01-25 Rieter Ag Maschf Verfahren zum Starten eines Arbeitsablaufs eines Bedienungsautomaten an einer Textilmaschine

Also Published As

Publication number Publication date
NO171344C (no) 1993-03-03
ATA141186A (de) 1990-06-15
GR861365B (en) 1986-09-29
SE462893B (sv) 1990-09-17
US5112609A (en) 1992-05-12
PT82647A (en) 1986-06-01
DK246886D0 (da) 1986-05-27
GB8612781D0 (en) 1986-07-02
ES555352A0 (es) 1987-07-01
PT82647B (pt) 1989-01-30
IL78937A (en) 1990-11-29
AU5796586A (en) 1986-12-04
AU569429B2 (en) 1988-01-28
DK246886A (da) 1986-11-29
IL78937A0 (en) 1986-09-30
FR2593393B1 (fr) 1989-06-02
NL8601354A (nl) 1986-12-16
GB2176703A (en) 1987-01-07
IT8648064A0 (it) 1986-05-27
HU200695B (en) 1990-08-28
FI862226A0 (fi) 1986-05-27
SE8602404L (sv) 1986-11-29
DK163174C (da) 1992-06-22
CA1297008C (en) 1992-03-10
NZ216306A (en) 1989-10-27
AT391812B (de) 1990-12-10
NO171344B (no) 1992-11-23
FI85334B (fi) 1991-12-31
FR2593393A1 (fr) 1987-07-31
GB2176703B (en) 1988-12-07
LU86445A1 (fr) 1986-12-05
HUT42330A (en) 1987-07-28
NO862095L (no) 1986-12-01
SE8602404D0 (sv) 1986-05-27
FI85334C (fi) 1992-04-10
ES8706443A1 (es) 1987-07-01
CH664495A5 (de) 1988-03-15
BE904831A (fr) 1986-11-27
IT1191925B (it) 1988-03-31
DE3617753C2 (fi) 1988-06-30
DK163174B (da) 1992-02-03
DE3617753A1 (de) 1986-12-04

Similar Documents

Publication Publication Date Title
FI900673A0 (fi) Antennsystem foer detektering av magnet- och resonanskretsar.
FI850004A0 (fi) Foerfarande foer identifiering av nukleinsyror.
FI862226A0 (fi) Foerfarande foer framstaellning av kompositioner innehaollande vaevnadsplasminogen-aktivator.
FI862803A0 (fi) Foerfarande foer framstaellande av gas- och vattentaeta kabelgenomfoeringar.
FI864454A0 (fi) Foerfarande foer behandling av textilytor.
FI850090A0 (fi) Foerfarande foer framstaellning av naturstensimitationer.
FI854341A0 (fi) Foerfarande foer avlaegsnande av koppar fraon kopparraffinaderielektrolyter.
FI850605A (fi) Foerfarande foer framstaellning av formar.
FI860609A0 (fi) Foerfarande foer framstaellning av blekt cellulosamassa utav ligninhaltigt raomaterial.
FI862588A0 (fi) Radiell placering av avdunstningselement.
FI865191A0 (fi) Foerfarande foer ytbehandling av folier.
FI862278A0 (fi) Foerfarande foer framstaellning av 11- substituerade steroider.
FI861017A0 (fi) Foerfarande foer aotercirkulering av metallsulfathaltig svavelsyra.
FI850208A0 (fi) Foerfarande foer styrning av alkaliska cellulosakok.
FI861928A0 (fi) Foerfarande foer tillverkning av verktyg foer bearbetning av foerdjupningar.
FI860219A (fi) Upphettning av bildroer.
FI850399L (fi) Uppvaermbart verktyg foer upphettning av roerfoerbindningsstycken.
FI850421A0 (fi) Foerfarande foer framstaellning av eldfasta tegelprodukter.
FI850353L (fi) Aendspont foer kantstoed av betong.
FI850120A0 (fi) Automatiseringsmetod av glasboejningsung.
FI850001A0 (fi) Anordning foer maetning av haerdningsgrad av betong.
FI850333A0 (fi) Anvaendning av torvaska.
FI850683L (fi) Anordning foer korsmaetning av fordon.
FI850660A0 (fi) Foerfarande foer framstaellning av 3-aryloxi-3-fenylpropylamin.
FI850420A0 (fi) Foerfarande foer maetning av fjaerrvaermefoerbrukning.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED